Comparing Erector Spinae Plane Block and Intrathecal Morphine for Recovery After Cesarean Section

What this Trial Is About

Researchers are evaluating the quality of recovery after cesarean section in women using two different pain management approaches the Erector Spinae Plane ESP Block and intrathecal morphine. Cesarean section is a common surgery that causes significant postoperative pain, which is usually managed with multiple medications. This study aims to compare these two methods to see which may better support recovery, including pain control, mobilization, breastfeeding, and hospital stay length. The study involves two groups of patients undergoing elective cesarean section with spinal anesthesia. One group will receive an ultrasound-guided bilateral ESP Block at the end of surgery using ropivacaine, while the other group will receive a standard dose of intrathecal morphine during spinal anesthesia. The study will assess pain relief and side effects from these treatments to find optimal pain management strategies. Participants will complete the Quality of Recovery-11 questionnaire on the first day after surgery to measure their recovery quality. Researchers will also monitor pain scores at various times, opioid use, side effects, time to mobilization, breastfeeding success, and hospital stay duration. The study starts in June 2025 and is led by AUSL Romagna Rimini, with participants followed closely for outcomes related to their postoperative recovery experience.

ESPB vs Intrathecal Morphine for Assessements of Quality of Recovery After Cesarean Section